超音波创市场－全球产业规模、份额、趋势、机会、预测：按产品类型、伤口类型、最终用户、地区和竞争对手划分，2021-2031年

全球超音波清创市场预计将从 2025 年的 1.5121 亿美元成长到 2031 年的 2.3362 亿美元，复合年增长率为 7.52%。

超音波技术的临床疗效是推动这一成长的主要因素。此技术利用低频声波和生理食盐水水清除生物膜和坏死组织，同时保护健康组织。推动该市场发展的主要因素是血管疾病和糖尿病盛行率的不断上升，以及全球人口老化对非侵入性、选择性清创治疗的需求。欧洲伤口管理协会 (EWMA) 2024 年的数据显示，在所分析的临床队列中，静脉性腿部溃疡占慢性伤口治疗的 26%，这凸显了此类有效治疗方法的必要性。

儘管市场驱动因素强劲，但由于超音波系统的高昂购置成本以及一次性牙科手机的持续使用费用，该市场仍面临许多障碍。这些经济障碍常常限制了超音波系统在地方诊所和小规模门诊机构的应用，因为预算限制往往迫使这些机构采用传统的、成本较低的清创方法。此外，各地不同的报销政策也带来了经济上的不确定性，这可能会阻碍这种先进治疗方法在医疗服务提供者中的推广和应用。

市场驱动因素

全球超音波创市场的主要驱动力是糖尿病足溃疡和慢性伤口的激增，这迫切需要先进的解决方案来控制感染和保护组织。该技术因其能够选择性地破碎坏死组织并分解生物膜而不损伤健康的肉芽组织而备受青睐。这对于治疗血液循环容易受损的糖尿病併发症至关重要。根据国际糖尿病联盟（IDF）预测，到2024年，全球将有约5.89亿糖尿病成人患者，这意味着庞大的患者群体中存在大量复杂的溃疡，需要进行精准且定期的清创治疗以防止截肢。

同时，随着高龄化社会的加剧，由于与老龄化相关的生理变化常常阻碍创伤治疗，对微创清创方法的需求日益增长。老年人通常皮肤脆弱且易患血管疾病，容易出现静脉溃疡等慢性损伤，因此不适合进行强力清创。根据发表于2024年4月《亚洲伤口》（Wounds Asia）杂誌上题为「慢性伤口：日益严重的公共卫生问题」的报导，美国65岁及以上人群中约有3%患有开放性伤口。这种不断增长的临床需求也反映在行业业绩中；例如，史密斯医疗（Smith+Nephew）于2025年2月发布的“2024年第四季度及全年财务业绩”显示，其先进伤口管理业务的核心收入增长了12.2%。

市场挑战

全球超音波清创市场发展面临的最大障碍是主机的高昂初始投资和一次性牙科手机的持续成本。这笔巨额投资构成了准入门槛，尤其对于预算有限的小规模门诊机构和社区诊所而言更是如此。与资金雄厚的医院不同，这些小规模医疗机构（其中许多慢性伤口在基层医疗机构进行管理）往往被迫优先使用传统的、价格低廉的机械器械，例如刮器和手术刀，而不是采用先进的超音波技术，从而限制了这项技术的广泛应用。

此外，整个医疗保健系统面临的经济压力也阻碍了对昂贵医疗设备的投资。根据美国居家医疗学会2024年的估计，慢性伤口治疗的年度成本在281亿美元至968亿美元之间。如此庞大的经济负担迫使医疗机构管理者实施严格的成本控制措施，这往往导致他们放弃资本密集型解决方案。因此，相对于报销率而言，高昂的拥有成本持续阻碍着超音波清创技术在医疗机构中的广泛应用。

市场趋势

全球超音波创术市场的关键趋势是向居家照护和门诊环境转移，这主要受分散式医疗服务需求的驱动。製造商正致力于开发携带式电池供电系统，使临床医生能够在非急性护理环境中进行精准的组织清除，从而减少住院时间和相关成本。这种转变有助于行动不便患者的治疗，并符合有利于社区管理的报销机制。康维特集团于2025年2月发布的2024财年财务业绩报告也印证了这项变化，报告显示，由于非医院领域的强劲应用，其有机收入增长加速至7.7%。

伴随这一转变，即时伤口回馈和数位化监测的整合也在不断发展，将清创设备转变为智慧诊断平台。开发人员正将感测器和成像技术直接整合到设备中，以帮助在手术过程中准确区分活组织和非活组织。这种治疗与诊断的融合增强了临床决策能力，并能够追踪癒合过程的进展。 Spectral AI 于 2025 年 10 月发布的新闻稿「Spectral AI 宣布获得 760 万美元资金筹措」充分体现了业界对这项创新的投入，该新闻稿详细介绍了用于扩展其「DeepView 系统」的资金筹措，该系统将先进的评估技术与治疗性介入结合。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球超音波创市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（手持设备、桌上型设备、配件）
  • 伤口类型（慢性伤口、急性伤口、烧伤、其他）
  • 按最终使用者（医院、门诊手术中心、居家医疗机构等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美超音波清创市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲超音波创术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区超音波术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲超音波清创术市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲超音波创市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球超音波清创市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• MISONIX, Inc.
• Smith & Nephew PLC
• Olympus Corporation
• SOring GmbH
• Esacrom SRL
• Hubei CFULL Medical Technology Co., Ltd
• Johnson & Johnson
• Beijing Sonicmed Technologies Co., Ltd.
• Hangzhou Yuanxiang Medical Technology Co., Ltd
• Hainertec（Suzhou）Co., Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Ultrasonic Debridement Market is projected to expand from USD 151.21 Million in 2025 to USD 233.62 Million by 2031, registering a CAGR of 7.52%. This growth is underpinned by the clinical efficacy of ultrasonic technology, which employs low-frequency sound waves and a saline medium to remove biofilm and necrotic debris while sparing healthy tissue. The market is primarily driven by the increasing prevalence of vascular diseases and diabetes, alongside an aging global population that demands non-traumatic, selective debridement options. The necessity for such effective therapies is highlighted by data from the European Wound Management Association in 2024, which noted that venous leg ulcers accounted for 26% of treated chronic wounds in analyzed clinical cohorts.

Despite the strong drivers, the market faces significant hurdles due to the high capital costs of ultrasonic systems and the recurring expenses associated with disposable handpieces. These financial barriers frequently restrict adoption in community clinics and smaller outpatient facilities, where budget limitations often dictate the use of traditional, lower-cost debridement methods. Furthermore, inconsistent reimbursement policies across different regions introduce economic uncertainty, which can hinder the widespread availability and uptake of this advanced treatment modality among healthcare providers.

Market Driver

A primary driver for the global ultrasonic debridement market is the surging prevalence of diabetic foot ulcers and chronic wounds, creating an urgent need for advanced solutions that ensure infection control and tissue preservation. The technology is highly valued for its ability to selectively fragment necrotic tissue and disrupt biofilm without damaging healthy granulation tissue, a crucial feature for managing diabetic complications where blood supply is often compromised. According to the International Diabetes Federation, an estimated 589 million adults were living with diabetes globally in 2024, representing a vast patient pool prone to complex ulcerations that require precise and regular debridement to prevent amputation.

Simultaneously, the expanding geriatric population is intensifying the demand for minimally invasive debridement options, as age-related physiological changes often impair wound healing. Older adults frequently suffer from fragile skin and vascular issues, making them susceptible to chronic lesions like venous leg ulcers that are unsuitable for aggressive sharp debridement. An April 2024 article by Wounds Asia titled 'Chronic wounds: a rising public health concern' indicated that approximately 3% of the U.S. population over age 65 suffers from open wounds. This growing clinical need is reflected in sector performance; for instance, Smith+Nephew's 'Fourth Quarter and Full Year 2024 Results' from February 2025 reported a 12.2% underlying revenue growth in their Advanced Wound Management business.

Market Challenge

The most significant challenge hindering the growth of the global ultrasonic debridement market is the high initial capital expenditure required for consoles and the recurring costs of disposable handpieces. This substantial financial investment acts as a barrier to entry, particularly for smaller outpatient facilities and community clinics that operate with limited budgets. Unlike well-funded hospitals, these smaller providers are often forced to forego advanced ultrasonic technology in favor of traditional, less expensive mechanical tools such as curettes or scalpels, thereby restricting the technology's reach in primary care settings where many chronic wounds are managed.

Furthermore, broader economic pressures on healthcare systems exacerbate the hesitation to invest in premium medical devices. According to the American Academy of Home Care Medicine in 2024, the estimated annual cost for managing chronic wounds ranged from $28.1 billion to $96.8 billion. This immense financial burden compels facility administrators to enforce strict cost-control measures, often resulting in the rejection of capital-intensive solutions. Consequently, the high cost of ownership relative to reimbursement rates continues to stifle the expansion of ultrasonic debridement into the wider healthcare landscape.

Market Trends

A pivotal trend in the global ultrasonic debridement market is the shift toward home care and outpatient settings, driven by the demand for decentralized healthcare delivery. Manufacturers are increasingly focusing on developing portable, battery-operated systems that allow clinicians to perform precise tissue removal outside of acute care environments, helping to reduce hospital lengths of stay and associated costs. This transition supports the treatment of immobile patients and aligns with reimbursement structures favoring community-based management, a shift evidenced by Convatec Group Plc's 'FY24 Results' in February 2025, which reported an accelerated organic revenue growth of 7.7% due to robust adoption in non-hospital sectors.

Concurrent with this shift is the integration of real-time wound feedback and digital monitoring, transforming debridement devices into intelligent diagnostic platforms. Developers are embedding sensors and imaging technologies directly into devices to help practitioners accurately distinguish between viable and non-viable tissue during procedures. This convergence of therapy and diagnostics enhances clinical decision-making and allows for longitudinal tracking of healing. The industry's commitment to this innovation is highlighted by Spectral AI, Inc.'s October 2025 press release, 'Spectral AI Announces $7.6 Million Offering', detailing the funding secured to expand its DeepView System, which couples advanced assessment technology with therapeutic intervention.

Key Market Players

• MISONIX, Inc.
• Smith & Nephew PLC
• Olympus Corporation
• SOring GmbH
• Esacrom S.R.L.
• Hubei CFULL Medical Technology Co., Ltd
• Johnson & Johnson
• Beijing Sonicmed Technologies Co., Ltd.
• Hangzhou Yuanxiang Medical Technology Co., Ltd
• Hainertec (Suzhou) Co., Ltd.

Report Scope

In this report, the Global Ultrasonic Debridement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ultrasonic Debridement Market, By Product Type

• Handheld Devices
• Desktop Devices
• Accessories

Ultrasonic Debridement Market, By Wound Type

• Chronic Wounds
• Acute Wounds
• Burn Wounds
• Others

Ultrasonic Debridement Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings
• Others

Ultrasonic Debridement Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ultrasonic Debridement Market.

Available Customizations:

Global Ultrasonic Debridement Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ultrasonic Debridement Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Handheld Devices, Desktop Devices, Accessories)
  • 5.2.2. By Wound Type (Chronic Wounds, Acute Wounds, Burn Wounds, Others)
  • 5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Ultrasonic Debridement Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Wound Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ultrasonic Debridement Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Wound Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Ultrasonic Debridement Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Wound Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Ultrasonic Debridement Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Wound Type
      • 6.3.3.2.3. By End User

7. Europe Ultrasonic Debridement Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Wound Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ultrasonic Debridement Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Wound Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Ultrasonic Debridement Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Wound Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Ultrasonic Debridement Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Wound Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Ultrasonic Debridement Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Wound Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Ultrasonic Debridement Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Wound Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Ultrasonic Debridement Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Wound Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ultrasonic Debridement Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Wound Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Ultrasonic Debridement Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Wound Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Ultrasonic Debridement Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Wound Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Ultrasonic Debridement Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Wound Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Ultrasonic Debridement Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Wound Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Ultrasonic Debridement Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Wound Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Ultrasonic Debridement Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Wound Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Ultrasonic Debridement Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Wound Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Ultrasonic Debridement Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Wound Type
      • 9.3.3.2.3. By End User

10. South America Ultrasonic Debridement Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Wound Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Ultrasonic Debridement Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Wound Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Ultrasonic Debridement Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Wound Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Ultrasonic Debridement Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Wound Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Ultrasonic Debridement Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. MISONIX, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Smith & Nephew PLC
• 15.3. Olympus Corporation
• 15.4. SOring GmbH
• 15.5. Esacrom S.R.L.
• 15.6. Hubei CFULL Medical Technology Co., Ltd
• 15.7. Johnson & Johnson
• 15.8. Beijing Sonicmed Technologies Co., Ltd.
• 15.9. Hangzhou Yuanxiang Medical Technology Co., Ltd
• 15.10. Hainertec (Suzhou) Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer